These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria. Morales E, Gutiérrez E, Caro J, Sevillano A, Rojas-Rivera J, Praga M. Nefrologia; 2015; 35(6):554-61. PubMed ID: 26519114 [Abstract] [Full Text] [Related]
6. Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months. González Monte E, Andrés A, Polanco N, Toribio MJ, Santana R, Gutiérrez Martínez E, González J, Ramírez E, Hernández A, Morales E, Praga M, Morales JM. Transplant Proc; 2010 Oct; 42(8):2899-901. PubMed ID: 20970564 [Abstract] [Full Text] [Related]
8. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. Tylicki L, Rutkowski P, Renke M, Larczyński W, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B. Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812 [Abstract] [Full Text] [Related]
9. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases. Bianchi S, Bigazzi R, Campese VM. Am J Kidney Dis; 2010 Apr; 55(4):671-81. PubMed ID: 20097461 [Abstract] [Full Text] [Related]
11. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker. Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T. Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019 [Abstract] [Full Text] [Related]
12. Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases. Morales E, Millet VG, Rojas-Rivera J, Huerta A, Gutiérrez E, Gutiérrez-Solís E, Egido J, Praga M. Nephrol Dial Transplant; 2013 Feb; 28(2):405-12. PubMed ID: 23222416 [Abstract] [Full Text] [Related]